Replication-competent influenza a viruses expressing reporter genes

Viruses

Volumn 8, Issue 7, 2016, Pages 1-28

  Breen, Michael ^a   Nogales, Aitor ^a   Baker, Steven F ^a   Martínez Sobrido, Luis ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Fluorescence; Luminescence; Plasmid based reverse genetics; Recombinant influenza A virus; Replicating competent reporter expressing influenza A virus; Reporter genes; Virus rescue approaches

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; GREEN FLUORESCENT PROTEIN; NUCLEOPORIN; OSELTAMIVIR; TRANSCRIPTASE; PHOTOPROTEIN;

BIOLUMINESCENCE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DNA FLANKING REGION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; FLUORESCENCE; FOOT AND MOUTH DISEASE VIRUS; FOREIGN GENE; GENE EXPRESSION; INFLUENZA A VIRUS; LD50; LUCIFERASE REPORTER GENE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REPORTER GENE; REVIEW; VIRULENCE; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING; GENETIC RECOMBINATION; GENETICS; HUMAN; PHYSIOLOGY; PROCEDURES; REVERSE GENETICS; STAINING; VIROLOGY;

GENE EXPRESSION; GENES, REPORTER; HUMANS; INFLUENZA A VIRUS; LUMINESCENT PROTEINS; RECOMBINATION, GENETIC; REVERSE GENETICS; STAINING AND LABELING; VIROLOGY; VIRUS REPLICATION;

EID: 84977126865     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8070179     Document Type: Review

References (123)

1. Palese, P.; Shaw, M. L. Orthomyxoviridae: The viruses and their replication. In Fields Virology, 5th ed.; Knipe, D. M., Howley, P. M., Griffin, D. E., Lamb, R. A., Martin, M. A., Eds.; LippincottWilliams andWilkins: Philadelphia, PA, USA, 2007.
2. Pritlove, D. C.; Fodor, E.; Seong, B. L.; Brownlee, G. G. In vitro transcription and polymerase binding studies of the termini of influenza A virus cRNA: Evidence for a cRNA panhandle. J. Gen. Virol. 1995, 76, 2205-2213. [CrossRef] [PubMed]
3. Flick, R.; Neumann, G.; Hoffmann, E.; Neumeier, E.; Hobom, G. Promoter elements in the influenza vRNAterminal structure. RNA 1996, 2, 1046-1057. [PubMed]
4. Medina, R. A.; Garcia-Sastre, A. Influenza A viruses: New research developments. Nat. Rev. Microbiol. 2011, 9, 590-603. [CrossRef] [PubMed]
5. WHO. Fluenza (Seasonal) Fact Sheet No. 211; WHO: Geneva, Switzerland, 2009.
6. Tong, S.; Zhu, X.; Li, Y.; Shi, M.; Zhang, J.; Bourgeois, M.; Yang, H.; Chen, X.; Recuenco, S.; Gomez, J.; et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013, 9, e1003657. [CrossRef] [PubMed]
7. Tong, S.; Li, Y.; Rivailler, P.; Conrardy, C.; Castillo, D. A.; Chen, L. M.; Recuenco, S.; Ellison, J. A.; Davis, C. T.; York, I. A.; et al. A distinct lineage of influenza A virus from bats. Proc. Natl. Acad. Sci. USA 2012, 109, 4269-4274. [CrossRef] [PubMed]
8. Skehel, J. J.; Wiley, D. C. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69, 531-569. [CrossRef] [PubMed]
9. Taubenberger, J. K. Influenza hemagglutinin attachment to target cells: 'Birds do it, we do it. '. Future Virol. 2006, 1, 415-418. [CrossRef] [PubMed]
10. Varghese, J. N.; Colman, P. M.; van Donkelaar, A.; Blick, T. J.; Sahasrabudhe, A.; McKimm-Breschkin, J. L. Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases. Proc. Natl. Acad. Sci. USA 1997, 94, 11808-11812. [CrossRef] [PubMed]
11. Varghese, J. N.; McKimm-Breschkin, J. L.; Caldwell, J. B.; Kortt, A. A.; Colman, P. M. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 1992, 14, 327-332. [CrossRef] [PubMed]
12. Jackson, R. J.; Cooper, K. L.; Tappenden, P.; Rees, A.; Simpson, E. L.; Read, R. C.; Nicholson, K. G. Oseltamivir, zanamivir and amantadine in the prevention of influenza: A systematic review. J. Infect. 2011, 62, 14-25. [CrossRef] [PubMed]
13. Oxford, J. S.; Mann, A.; Lambkin, R. A designer drug against influenza: The NA inhibitor oseltamivir (Tamiflu). Expert Rev. Anti Infect. Ther. 2003, 1, 337-342. [PubMed]
14. Resa-Infante, P.; Jorba, N.; Coloma, R.; Ortin, J. The influenza virus rna synthesis machine: Advances in its structure and function. RNA Biol. 2011, 8, 207-215. [CrossRef] [PubMed]
15. Wise, H. M.; Hutchinson, E. C.; Jagger, B. W.; Stuart, A. D.; Kang, Z. H.; Robb, N.; Schwartzman, L. M.; Kash, J. C.; Fodor, E.; Firth, A. E.; et al. Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog. 2012, 8, e1002998. [CrossRef] [PubMed]
16. Paterson, D.; Fodor, E. Emerging roles for the influenza A virus nuclear export protein (NEP). PLoS Pathog. 2012, 8, e1003019. [CrossRef] [PubMed]
17. Hai, R.; Schmolke, M.; Varga, Z. T.; Manicassamy, B.; Wang, T. T.; Belser, J. A.; Pearce, M. B.; Garcia-Sastre, A.; Tumpey, T. M.; Palese, P. Pb1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J. Virol. 2010, 84, 4442-4450. [CrossRef] [PubMed]
18. Jagger, B. W.; Wise, H. M.; Kash, J. C.; Walters, K. A.; Wills, N. M.; Xiao, Y. L.; Dunfee, R. L.; Schwartzman, L. M.; Ozinsky, A.; Bell, G. L.; et al. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 2012, 337, 199-204. [CrossRef] [PubMed]
19. Wise, H. M.; Foeglein, A.; Sun, J.; Dalton, R. M.; Patel, S.; Howard, W.; Anderson, E. C.; Barclay, W. S.; Digard, P. A complicated message: Identification of a novel pb1-related protein translated from influenza A virus segment 2 mRNA. J. Virol. 2009, 83, 8021-8031. [CrossRef] [PubMed]
20. Hale, B. G.; Randall, R. E.; Ortin, J.; Jackson, D. The multifunctional ns1 protein of influenza A viruses. J. Gen. Virol. 2008, 89, 2359-2376. [CrossRef] [PubMed]
21. Lamb, R. A.; Lai, C. J. Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell 1980, 21, 475-485. [CrossRef]
22. Smith, G. J. D.; Bahl, J.; Vijaykrishna, D.; Zhang, J. X.; Poon, L. L. M.; Chen, H. L.; Webster, R. G.; Peiris, J. S. M.; Guan, Y. Dating the emergence of pandemic influenza viruses. Proc. Natl. Acad. Sci. USA 2009, 106, 11709-11712. [CrossRef] [PubMed]
23. Jadhao, S. J.; Nguyen, D. C.; Uyeki, T. M.; Shaw, M.; Maines, T.; Rowe, T.; Smith, C.; Huynh, L. P.; Nghiem, H. K.; Nguyen, D. H.; et al. Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004. Arch. Virol. 2009, 154, 1249-1261. [CrossRef] [PubMed]
24. Kilbourne, E. D. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 2006, 12, 9-14. [CrossRef] [PubMed]
25. Herfst, S.; Schrauwen, E. J.; Linster, M.; Chutinimitkul, S.; de Wit, E.; Munster, V. J.; Sorrell, E. M.; Bestebroer, T. M.; Burke, D. F.; Smith, D. J.; et al. Airborne transmission of influenza A/h5n1 virus between ferrets. Science 2012, 336, 1534-1541. [CrossRef] [PubMed]
26. Imai, M.; Watanabe, T.; Hatta, M.; Das, S. C.; Ozawa, M.; Shinya, K.; Zhong, G.; Hanson, A.; Katsura, H.; Watanabe, S.; et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012, 486, 420-428. [CrossRef] [PubMed]
27. Uyeki, T. M.; Cox, N. J. Global concerns regarding novel influenza A (H7N9) virus infections. N. Engl. J. Med. 2013, 368, 1862-1864. [CrossRef] [PubMed]
28. Aamir, U. B.; Naeem, K.; Ahmed, Z.; Obert, C. A.; Franks, J.; Krauss, S.; Seiler, P.; Webster, R. G. Zoonotic potential of highly pathogenic avian H7N3 influenza viruses from pakistan. Virology 2009, 390, 212-220. [CrossRef] [PubMed]
29. Osterholm, M. T.; Kelley, N. S.; Sommer, A.; Belongia, E. A. Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis. Lancet Infect. Dis. 2012, 12, 36-44. [CrossRef]
30. Beigel, J.; Bray, M. Current and future antiviral therapy of severe seasonal and avian influenza. Antivir. Res. 2008, 78, 91-102. [CrossRef] [PubMed]
31. Garcia-Sastre, A. Antiviral response in pandemic influenza viruses. Emerg. Infect. Dis. 2006, 12, 44-47. [CrossRef] [PubMed]
32. Carrat, F.; Flahault, A. Influenza vaccine: The challenge of antigenic drift. Vaccine 2007, 25, 6852-6862. [CrossRef] [PubMed]
33. Beyleveld, G.; White, K. M.; Ayllon, J.; Shaw, M. L. New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions. Antivir. Res. 2013, 100, 120-132. [CrossRef] [PubMed]
34. Fujii, K.; Ozawa, M.; Iwatsuki-Horimoto, K.; Horimoto, T.; Kawaoka, Y. Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences. J. Gen. Virol. 2009, 90, 1734-1740. [CrossRef] [PubMed]
35. Watanabe, T.; Watanabe, S.; Noda, T.; Fujii, Y.; Kawaoka, Y. Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J. Virol. 2003, 77, 10575-10583. [CrossRef] [PubMed]
36. Fujii, Y.; Goto, H.; Watanabe, T.; Yoshida, T.; Kawaoka, Y. Selective incorporation of influenza virus RNA segments into virions. Proc. Natl. Acad. Sci. USA 2003, 100, 2002-2007. [CrossRef] [PubMed]
37. Hutchinson, E. C.; von Kirchbach, J. C.; Gog, J. R.; Digard, P. Genome packaging in influenza A virus. J. Gen. Virol. 2010, 91, 313-328. [CrossRef] [PubMed]
38. Fukuyama, S.; Katsura, H.; Zhao, D.; Ozawa, M.; Ando, T.; Shoemaker, J. E.; Ishikawa, I.; Yamada, S.; Neumann, G.; Watanabe, S.; et al. Multi-spectral fluorescent reporter influenza viruses (Color-flu) as powerful tools for in vivo studies. Nat. Commun. 2015, 6, 6600. [CrossRef] [PubMed]
39. Fiege, J. K.; Langlois, R. A. Investigating influenza A virus infection: Tools to track infection and limit tropism. J. Virol. 2015, 89, 6167-6170. [CrossRef] [PubMed]
40. Nogales, A.; Rodriguez-Sanchez, I.; Monte, K.; Lenschow, D. J.; Perez, D. R.; Martinez-Sobrido, L. Replication-competent fluorescent-expressing influenza b virus. Virus Res. 2015, 213, 69-81. [CrossRef] [PubMed]
41. Nogales, A.; Baker, S. F.; Martinez-Sobrido, L. Replication-competent influenza A viruses expressing a red fluorescent protein. Virology 2014, 476, 206-216. [CrossRef] [PubMed]
42. Shaner, N. C.; Patterson, G. H.; Davidson, M. W. Advances in fluorescent protein technology. J. Cell Sci. 2007, 120, 4247-4260. [CrossRef] [PubMed]
43. Shaner, N. C.; Steinbach, P. A.; Tsien, R. Y. A guide to choosing fluorescent proteins. Nat. Methods 2005, 2, 905-909. [CrossRef] [PubMed]
44. Welsh, D. K.; Noguchi, T. Cellular bioluminescence imaging. Cold Spring Harb. Protoc. 2012, 2012. [CrossRef]
45. Shimomura, O.; Johnson, F. H.; Saiga, Y. Extraction, purification and properties of aequorin, a bioluminescent protein from the Luminous Hydromedusan, Aequorea. J. Cell. Comp. Physiol. 1962, 59, 223-239. [CrossRef] [PubMed]
46. Kelkar, M.; De, A. Bioluminescence based in vivo screening technologies. Curr. Opin. Pharmacol. 2012, 12, 592-600. [CrossRef] [PubMed]
47. DeWet, J. R.; Wood, K. V.; DeLuca, M.; Helinski, D. R.; Subramani, S. Firefly luciferase gene: Structure and expression in mammalian cells. Mol. Cell. Biol. 1987, 7, 725-737. [CrossRef] [PubMed]
48. Eckert, N.; Wrensch, F.; Gartner, S.; Palanisamy, N.; Goedecke, U.; Jager, N.; Pohlmann, S.; Winkler, M. Influenza A virus encoding secreted gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins. PLoS ONE 2014, 9, e97695. [CrossRef] [PubMed]
49. Hall, M. P.; Unch, J.; Binkowski, B. F.; Valley, M. P.; Butler, B. L.; Wood, M. G.; Otto, P.; Zimmerman, K.; Vidugiris, G.; Machleidt, T.; et al. Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem. Biol. 2012, 7, 1848-1857. [CrossRef] [PubMed]
50. Tran, V.; Poole, D. S.; Jeffery, J. J.; Sheahan, T. P.; Creech, D.; Yevtodiyenko, A.; Peat, A. J.; Francis, K. P.; You, S.; Mehle, A. Multi-modal imaging with a toolbox of influenza A reporter viruses. Viruses 2015, 7, 5319-5327. [CrossRef] [PubMed]
51. Zhao, H.; Doyle, T. C.; Coquoz, O.; Kalish, F.; Rice, B. W.; Contag, C. H. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J. Biomed. Opt. 2005, 10, 41210. [CrossRef] [PubMed]
52. Tran, V.; Moser, L. A.; Poole, D. S.; Mehle, A. Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread. J. Virol. 2013, 87, 13321-13329. [CrossRef] [PubMed]
53. Guilligay, D.; Tarendeau, F.; Resa-Infante, P.; Coloma, R.; Crepin, T.; Sehr, P.; Lewis, J.; Ruigrok, R. W.; Ortin, J.; Hart, D. J.; et al. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat. Struct. Mol. Biol. 2008, 15, 500-506. [CrossRef] [PubMed]
54. Engelhardt, O. G.; Fodor, E. Functional association between viral and cellular transcription during influenza virus infection. Rev. Med. Virol. 2006, 16, 329-345. [CrossRef] [PubMed]
55. Hutchinson, E. C.; Charles, P. D.; Hester, S. S.; Thomas, B.; Trudgian, D.; Martinez-Alonso, M.; Fodor, E. Conserved and host-specific features of influenza virion architecture. Nat. Commun. 2014, 5, 4816. [CrossRef] [PubMed]
56. Taubenberger, J. K.; Kash, J. C. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 2010, 7, 440-451. [CrossRef] [PubMed]
57. Konig, R.; Stertz, S.; Zhou, Y.; Inoue, A.; Hoffmann, H. H.; Bhattacharyya, S.; Alamares, J. G.; Tscherne, D. M.; Ortigoza, M. B.; Liang, Y.; et al. Human host factors required for influenza virus replication. Nature 2010, 463, 813-817. [CrossRef] [PubMed]
58. Avilov, S. V.; Moisy, D.; Munier, S.; Schraidt, O.; Naffakh, N.; Cusack, S. Replication-competent influenza A virus that encodes a split-green fluorescent protein-tagged PB2 polymerase subunit allows live-cell imaging of the virus life cycle. J. Virol. 2012, 86, 1433-1448. [CrossRef] [PubMed]
59. Cabantous, S.; Terwilliger, T. C.; Waldo, G. S. Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat. Biotechnol. 2005, 23, 102-107. [CrossRef] [PubMed]
60. Crescenzo-Chaigne, B.; Naffakh, N.; van der Werf, S. Comparative analysis of the ability of the polymerase complexes of influenza viruses type A, B and C to assemble into functional rnps that allow expression and replication of heterotypic model RNA templates in vivo. Virology 1999, 265, 342-353. [CrossRef] [PubMed]
61. Avilov, S. V.; Moisy, D.; Naffakh, N.; Cusack, S. Influenza A virus progeny vrnp trafficking in live infected cells studied with the virus-encoded fluorescently tagged PB2 protein. Vaccine 2012, 30, 7411-7417. [CrossRef] [PubMed]
62. Jing, J.; Prekeris, R. Polarized endocytic transport: The roles of rab11 and rab11-fips in regulating cell polarity. Histol. Histopathol. 2009, 24, 1171-1180. [PubMed]
63. Eisfeld, A. J.; Kawakami, E.; Watanabe, T.; Neumann, G.; Kawaoka, Y. Rab11a is essential for transport of the influenza virus genome to the plasma membrane. J. Virol. 2011, 85, 6117-6126. [CrossRef] [PubMed]
64. Jo, S.; Kawaguchi, A.; Takizawa, N.; Morikawa, Y.; Momose, F.; Nagata, K. Involvement of vesicular trafficking system in membrane targeting of the progeny influenza virus genome. Microbes Infect. 2010, 12, 1079-1084. [CrossRef] [PubMed]
65. Bruce, E. A.; Digard, P.; Stuart, A. D. The rab11 pathway is required for influenza A virus budding and filament formation. J. Virol. 2010, 84, 5848-5859. [CrossRef] [PubMed]
66. Heaton, N. S.; Leyva-Grado, V. H.; Tan, G. S.; Eggink, D.; Hai, R.; Palese, P. in vivo bioluminescent imaging of influenza A virus infection and characterization of novel cross-protective monoclonal antibodies. J. Virol. 2013, 87, 8272-8281. [CrossRef] [PubMed]
67. Yan, D.; Weisshaar, M.; Lamb, K.; Chung, H. K.; Lin, M. Z.; Plemper, R. K. Replication-competent influenza virus and respiratory syncytial virus luciferase reporter strains engineered for co-infections identify antiviral compounds in combination screens. Biochemistry 2015, 54, 5589-5604. [CrossRef] [PubMed]
68. Breen, M.; Nogales, A.; Baker, S. F.; Perez, D. R.; Martinez-Sobrido, L. Replication-competent influenza A and b viruses expressing a fluorescent dynamic timer protein for in vitro and in vivo studies. PLoS ONE 2016, 11, e0147723. [CrossRef] [PubMed]
69. Karlsson, E. A.; Meliopoulos, V. A.; Savage, C.; Livingston, B.; Mehle, A.; Schultz-Cherry, S. Visualizing real-time influenza virus infection, transmission and protection in ferrets. Nat. Commun. 2015, 6, 6378. [CrossRef] [PubMed]
70. Li, F.; Feng, L.; Pan, W.; Dong, Z.; Li, C.; Sun, C.; Chen, L. Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segment. J. Virol. 2010, 84, 12075-12081. [CrossRef] [PubMed]
71. Manicassamy, B.; Manicassamy, S.; Belicha-Villanueva, A.; Pisanelli, G.; Pulendran, B.; Garcia-Sastre, A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. USA 2010, 107, 11531-11536. [CrossRef] [PubMed]
72. Pan, W.; Dong, Z.; Li, F.; Meng, W.; Feng, L.; Niu, X.; Li, C.; Luo, Q.; Li, Z.; Sun, C.; et al. Visualizing influenza virus infection in living mice. Nat. Commun. 2013, 4, 2369. [CrossRef] [PubMed]
73. Spronken, M. I.; Short, K. R.; Herfst, S.; Bestebroer, T. M.; Vaes, V. P.; van der Hoeven, B.; Koster, A. J.; Kremers, G. J.; Scott, D. P.; Gultyaev, A. P.; et al. Optimisations and challenges involved in the creation of various bioluminescent and fluorescent influenza A virus strains for in vitro and in vivo applications. PLoS ONE 2015, 10, e0133888. [CrossRef] [PubMed]
74. Sharma, P.; Yan, F.; Doronina, V. A.; Escuin-Ordinas, H.; Ryan, M. D.; Brown, J. D. 2A peptides provide distinct solutions to driving stop-carry on translational recoding. Nucleic Acids Res. 2012, 40, 3143-3151. [CrossRef] [PubMed]
75. Sui, J.; Hwang, W. C.; Perez, S.; Wei, G.; Aird, D.; Chen, L. M.; Santelli, E.; Stec, B.; Cadwell, G.; Ali, M.; et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 2009, 16, 265-273. [CrossRef] [PubMed]
76. He, W.; Mullarkey, C. E.; Miller, M. S. Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay. Methods 2015, 90, 95-100. [CrossRef] [PubMed]
77. Hai, R.; Krammer, F.; Tan, G. S.; Pica, N.; Eggink, D.; Maamary, J.; Margine, I.; Albrecht, R. A.; Palese, P. Influenza viruses expressing chimeric hemagglutinins: Globular head and stalk domains derived from different subtypes. J. Virol. 2012, 86, 5774-5781. [CrossRef] [PubMed]
78. Hoffmann, H. H.; Kunz, A.; Simon, V. A.; Palese, P.; Shaw, M. L. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc. Natl. Acad. Sci. USA 2011, 108, 5777-5782. [CrossRef] [PubMed]
79. Baker, S. F.; Guo, H.; Albrecht, R. A.; Garcia-Sastre, A.; Topham, D. J.; Martinez-Sobrido, L. Protection against lethal influenza with a viral mimic. J. Virol. 2013, 87, 8591-8605. [CrossRef] [PubMed]
80. Munier, S.; Rolland, T.; Diot, C.; Jacob, Y.; Naffakh, N. Exploration of binary virus-host interactions using an infectious protein complementation assay. Mol. Cell. Proteom. 2013, 12, 2845-2855. [CrossRef] [PubMed]
81. Sidwell, R. W.; Bailey, K. W.; Wong, M. H.; Barnard, D. L.; Smee, D. F. In vitro and in vivo influenza virus-inhibitory effects of viramidine. Antivir. Res. 2005, 68, 10-17. [CrossRef] [PubMed]
82. Takeda, M.; Pekosz, A.; Shuck, K.; Pinto, L. H.; Lamb, R. A. Influenza A virus M2 ion channel activity is essential for efficient replication in tissue culture. J. Virol. 2002, 76, 1391-1399. [CrossRef] [PubMed]
83. Fodor, E.; Smith, M. The pa subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex. J. Virol. 2004, 78, 9144-9153. [CrossRef] [PubMed]
84. Nogales, A.; Baker, S. F.; Domm, W.; Martinez-Sobrido, L. Development and applications of single-cycle infectious influenza A virus (sciIAV). Virus Res 2016, 216, 26-40. [CrossRef] [PubMed]
85. Liang, Y.; Hong, Y.; Parslow, T. G. Cis-acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments. J. Virol. 2005, 79, 10348-10355. [CrossRef] [PubMed]
86. Steel, J.; Lowen, A. C.; Mubareka, S.; Palese, P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 2009, 5, e1000252. [CrossRef] [PubMed]
87. Lakdawala, S. S.; Wu, Y.; Wawrzusin, P.; Kabat, J.; Broadbent, A. J.; Lamirande, E. W.; Fodor, E.; Altan-Bonnet, N.; Shroff, H.; Subbarao, K. Influenza A virus assembly intermediates fuse in the cytoplasm. PLoS Pathog. 2014, 10, e1003971. [CrossRef] [PubMed]
88. Fouchier, R. A.; Garcia-Sastre, A.; Kawaoka, Y.; Barclay, W. S.; Bouvier, N. M.; Brown, I. H.; Capua, I.; Chen, H.; Compans, R. W.; Couch, R. B.; et al. Transmission studies resume for avian flu. Science 2013, 339, 520-521. [CrossRef] [PubMed]
89. Perez, J. T.; Garcia-Sastre, A.; Manicassamy, B. Insertion of a GFP reporter gene in influenza virus. Curr. Protoc. Microbiol. 2013. [CrossRef]
90. Kittel, C.; Sereinig, S.; Ferko, B.; Stasakova, J.; Romanova, J.; Wolkerstorfer, A.; Katinger, H.; Egorov, A. Rescue of influenza virus expressing gfp from the NS1 reading frame. Virology 2004, 324, 67-73. [CrossRef] [PubMed]
91. Da Silva, D. V.; Nordholm, J.; Dou, D.; Wang, H.; Rossman, J. S.; Daniels, R. The influenza virus neuraminidase protein transmembrane and head domains have coevolved. J. Virol. 2015, 89, 1094-1104. [CrossRef] [PubMed]
92. Yang, X.; Steukers, L.; Forier, K.; Xiong, R.; Braeckmans, K.; Van Reeth, K.; Nauwynck, H. A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucus. PLoS ONE 2014, 9, e110026. [CrossRef] [PubMed]
93. Machado, A. V.; Naffakh, N.; van der Werf, S.; Escriou, N. Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter. Virology 2003, 313, 235-249. [CrossRef]
94. Machado, A. V.; Naffakh, N.; Gerbaud, S.; van der Werf, S.; Escriou, N. Recombinant influenza A viruses harboring optimized dicistronic na segment with an extended native 5' terminal sequence: Induction of heterospecific B and T cell responses in mice. Virology 2006, 345, 73-87. [CrossRef] [PubMed]
95. Perez, D. R.; Garcia-Sastre, A. H5N1, a wealth of knowledge to improve pandemic preparedness. Virus Res. 2013, 178, 1-2. [CrossRef] [PubMed]
96. Perez, D. R.; Lim, W.; Seiler, J. P.; Yi, G.; Peiris, M.; Shortridge, K. F.; Webster, R. G. Role of quail in the interspecies transmission of H9 influenza A viruses: Molecular changes on ha that correspond to adaptation from ducks to chickens. J. Virol. 2003, 77, 3148-3156. [CrossRef] [PubMed]
97. Pena, L.; Sutton, T.; Chockalingam, A.; Kumar, S.; Angel, M.; Shao, H.; Chen, H.; Li, W.; Perez, D. R. Influenza viruses with rearranged genomes as live-attenuated vaccines. J. Virol. 2013, 87, 5118-5127. [CrossRef] [PubMed]
98. Kimble, J. B.; Sorrell, E.; Shao, H.; Martin, P. L.; Perez, D. R. Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model. Proc. Natl. Acad. Sci. USA 2011, 108, 12084-12088. [CrossRef] [PubMed]
99. Sutton, T. C.; Obadan, A.; Lavigne, J.; Chen, H.; Li, W.; Perez, D. R. Genome rearrangement of influenza virus for anti-viral drug screening. Virus Res 2014, 189, 14-23. [CrossRef] [PubMed]
100. Kittel, C.; Ferko, B.; Kurz, M.; Voglauer, R.; Sereinig, S.; Romanova, J.; Stiegler, G.; Katinger, H.; Egorov, A. Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the ns gene segment. J. Virol. 2005, 79, 10672-10677. [CrossRef] [PubMed]
101. Gabor, K. A.; Goody, M. F.; Mowel, W. K.; Breitbach, M. E.; Gratacap, R. L.; Witten, P. E.; Kim, C. H. Influenza A virus infection in zebrafish recapitulates mammalian infection and sensitivity to anti-influenza drug treatment. Dis. Models Mech. 2014, 7, 1227-1237. [CrossRef] [PubMed]
102. Pang, I. K.; Pillai, P. S.; Iwasaki, A. Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I. Proc. Natl. Acad. Sci. USA 2013, 110, 13910-13915. [CrossRef] [PubMed]
103. Resa-Infante, P.; Thieme, R.; Ernst, T.; Arck, P. C.; Ittrich, H.; Reimer, R.; Gabriel, G. Importin-alpha7 is required for enhanced influenza A virus replication in the alveolar epithelium and severe lung damage in mice. J. Virol. 2014, 88, 8166-8179. [CrossRef] [PubMed]
104. Roberts, K. L.; Manicassamy, B.; Lamb, R. A. Influenza A virus uses intercellular connections to spread to neighboring cells. J. Virol. 2015, 89, 1537-1549. [CrossRef] [PubMed]
105. De Baets, S.; Verhelst, J.; Van den Hoecke, S.; Smet, A.; Schotsaert, M.; Job, E. R.; Roose, K.; Schepens, B.; Fiers, W.; Saelens, X. A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody. PLoS ONE 2015, 10, e0121491. [CrossRef] [PubMed]
106. Reuther, P.; Gopfert, K.; Dudek, A. H.; Heiner, M.; Herold, S.; Schwemmle, M. Generation of a variety of stable influenza A reporter viruses by genetic engineering of the ns gene segment. Sci. Rep. 2015, 5, 11346. [CrossRef] [PubMed]
107. Horvath, C. M.; Williams, M. A.; Lamb, R. A. Eukaryotic coupled translation of tandem cistrons: Identification of the influenza B virus BM2 polypeptide. EMBO J. 1990, 9, 2639-2647. [PubMed]
108. Basler, C. F.; Reid, A. H.; Dybing, J. K.; Janczewski, T. A.; Fanning, T. G.; Zheng, H.; Salvatore, M.; Perdue, M. L.; Swayne, D. E.; Garcia-Sastre, A.; et al. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc. Natl. Acad. Sci. USA 2001, 98, 2746-2751. [CrossRef] [PubMed]
109. + dendritic cells are protected from influenza virus infection. J. Clin. Investig. 2012, 122, 4037-4047. [CrossRef] [PubMed]
110. Hufford, M. M.; Richardson, G.; Zhou, H.; Manicassamy, B.; Garcia-Sastre, A.; Enelow, R. I.; Braciale, T. J. Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells. PLoS ONE 2012, 7, e46581. [CrossRef] [PubMed]
111. Kato, H.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Uematsu, S.; Matsui, K.; Tsujimura, T.; Takeda, K.; Fujita, T.; Takeuchi, O.; et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005, 23, 19-28. [CrossRef] [PubMed]
112. Kim, J. I.; Park, S.; Lee, I.; Lee, S.; Shin, S.; Won, Y.; Hwang, M. W.; Bae, J. Y.; Heo, J.; Hyun, H. E.; et al. GFP-expressing influenza A virus for evaluation of the efficacy of antiviral agents. J. Microbiol. 2012, 50, 359-362. [CrossRef] [PubMed]
113. Brass, A. L.; Huang, I. C.; Benita, Y.; John, S. P.; Krishnan, M. N.; Feeley, E. M.; Ryan, B. J.; Weyer, J. L.; van derWeyden, L.; Fikrig, E.; et al. The ifitm proteins mediate cellular resistance to influenza A H1N1 virus, west nile virus, and dengue virus. Cell 2009, 139, 1243-1254. [CrossRef] [PubMed]
114. Huang, I. C.; Bailey, C. C.; Weyer, J. L.; Radoshitzky, S. R.; Becker, M. M.; Chiang, J. J.; Brass, A. L.; Ahmed, A. A.; Chi, X.; Dong, L.; et al. Distinct patterns of ifitm-mediated restriction of filoviruses, sars coronavirus, and influenza A virus. PLoS Pathog. 2011, 7, e1001258. [CrossRef] [PubMed]
115. Amini-Bavil-Olyaee, S.; Choi, Y. J.; Lee, J. H.; Shi, M.; Huang, I. C.; Farzan, M.; Jung, J. U. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 2013, 13, 452-464. [CrossRef] [PubMed]
116. Cenedella, R. J. Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 2009, 44, 477-487. [CrossRef] [PubMed]
117. Terskikh, A.; Fradkov, A.; Ermakova, G.; Zaraisky, A.; Tan, P.; Kajava, A. V.; Zhao, X.; Lukyanov, S.; Matz, M.; Kim, S.; et al. "Fluorescent timer": Protein that changes color with time. Science 2000, 290, 1585-1588. [CrossRef] [PubMed]
118. Yen, H. L.; Webster, R. G. Pandemic influenza As a current threat. Curr. Top. Microbiol. Immunol. 2009, 333, 3-24. [PubMed]
119. Taubenberger, J. K.; Morens, D. M. 1918 influenza: The mother of all pandemics. Emerg. Infect. Dis. 2006, 12, 15-22. [CrossRef] [PubMed]
120. Wang, X.; Basler, C. F.; Williams, B. R.; Silverman, R. H.; Palese, P.; Garcia-Sastre, A. Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J. Virol. 2002, 76, 12951-12962. [CrossRef] [PubMed]
121. Neirynck, S.; Deroo, T.; Saelens, X.; Vanlandschoot, P.; Jou, W. M.; Fiers, W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 1999, 5, 1157-1163. [PubMed]
122. Martinez-Sobrido, L.; Garcia-Sastre, A. Generation of recombinant influenza virus from plasmid DNA. J. Vis. Exp. 2010, 42, e2057. [CrossRef] [PubMed]
123. Hoffmann, E.; Neumann, G.; Kawaoka, Y.; Hobom, G.; Webster, R. G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 2000, 97, 6108-6113. [CrossRef] [PubMed]